$CERT News

Certara, Inc. 2026 Q2 - Results - Earnings Call Presentation

Certara, Inc. (CERT) Q2 2026 Earnings Call Transcript

Transcript: Certara Q2 2026 Earnings Conference Call

Certara Lowers FY2026 Adj EPS Guidance from $0.35-$0.41 to $0.31-$0.36 vs $0.38 Est; Lowers FY2026 Sales Guidance from $395.000M-$405.000M to $367.000M-$382.000M vs $398.585M Est

Certara Q2 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $93.271M Miss $98.392M Estimate

Certara Partners With NVIDIA To Advance Its Open Integrated AI Platform, Unifying Scientific Software, Regulatory Expertise, And Proprietary Datasets With AI-First, Agentic Frameworks

Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets

Certara Announces CFO Transition

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference

How Certara (CERT) Investors Can Read The Quiet Shift In The Valuation Story

Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Is Now An Opportune Moment To Examine Certara, Inc. (NASDAQ:CERT)?

Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Certara to Participate in Upcoming Investor Conferences

Craig-Hallum Maintains Hold on Certara, Lowers Price Target to $8

BMO Capital Maintains Market Perform on Certara, Lowers Price Target to $6

Barclays Maintains Equal-Weight on Certara, Lowers Price Target to $6.5

Stephens & Co. Maintains Overweight on Certara, Lowers Price Target to $9

Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $10

Baird Maintains Neutral on Certara, Lowers Price Target to $6